Influence of a glutamate carboxypeptidase II (GCPII) polymorphism (1561C→T) on plasma homocysteine, folate and vitamin B12 levels and its relationship to cardiovascular disease risk

Atherosclerosis

Volumn 164, Issue 2, 2002, Pages 269-273

  Lievers, Karin J A ^a   Kluijtmans, Leo A J ^a   Boers, Godfried H J ^a   Verhoef, Petra ^b   Den Heijer, Martin ^a   Trijbels, Frans J M ^a   Blom, Henk J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Cardiovascular disease; Glutamate carboxypeptidase II (GCPII); Homocysteine; Hyperhomocysteinemia; Polymorphism

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; GAMMA GLUTAMYL HYDROLASE; HOMOCYSTEINE; METHIONINE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET RESTRICTION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ERYTHROCYTE; FEMALE; GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

ADULT; ANALYSIS OF VARIANCE; ANTIGENS, SURFACE; CARBOXYPEPTIDASES; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTAMATE CARBOXYPEPTIDASE II; HOMOCYSTEINE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VITAMIN B 12;

EID: 0036801570     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00065-5     Document Type: Article

References (18)

1. Boushey C.J., Beresford S.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J. Am. Med. Assoc. 274:1995;1049-1057.
2. Graham I.M., Daly L.E., Refsum H.M., et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. J. Am. Med. Assoc. 277:1997;1775-1781.
3. Morrison H.I., Schaubel D., Desmeules M., Wigle D.T. Serum folate and risk of fatal coronary heart disease. J. Am. Med. Assoc. 275:1996;1893-1896.
4. Silberberg J.S., Crooks R.L., Wlodarczyk J.H., Fryer J.L. Association between plasma folate and coronary disease independent of homocysteine. Am. J. Cardiol. 87:2001;1003-1004.
5. Voutilainen S., Rissanen T.H., Virtanen J., Lakka T.A., Salonen J.T. Low dietary folate intake is associated with an excess incidence of acute coronary events: The Kuopio Ischemic Heart Disease Risk Factor Study. Circulation. 103:2001;2674-2680.
6. Engbersen A.M., Franken D.G., Boers G.H., Stevens E.M., Trijbels F.J., Blom H.J. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am. J. Hum. Genet. 56:1995;142-150.
7. Harmon D.L., Woodside J.V., Yarnell J.W., et al. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM. 89:1996;571-577.
8. Verhoef P., Kok F.J., Kluijtmans L.A., et al. The 677C→T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis. 132:1997;105-113.
9. Nygard O., Refsum H., Ueland P.M., Vollset S.E. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am. J. Clin. Nutr. 67:1998;263-270.
10. Selhub J., Jacques P.F., Rosenberg I.H., et al. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann. Intern. Med. 131:1999;331-339.
11. Devlin A.M., Ling E.H., Peerson J.M., et al. Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. Hum. Mol. Genet. 9:2000;2837-2844.
12. Verhoef P., Kok F.J., Kruyssen D.A., et al. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17:1997;989-995.
13. Kluijtmans L.A., van den Heuvel L.P., Boers G.H., et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am. J. Hum. Genet. 58:1996;35-41.
14. Den Heijer M., Blom H.J., Gerrits W.B., et al. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet. 345:1995;882-885.
15. Boers G.H., Smals A.G., Trijbels F.J., et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. New Engl. J. Med. 313:1985;709-715.
16. Te Poele-Pothoff M.T., van den Berg M., Franken D.G., et al. Three different methods for the determination of total homocysteine in plasma. Ann. Clin. Biochem. 32:1995;218-220.
17. Brancaccio R, Passariello A, Buoninconti A, et al. Multiple genotyping for genes of the folate/methionine metabolism in Italian NTD patients. Abstracts Book of 3rd International Conference on Homocysteine Metabolism 2001 (Abstract)
18. Selhub J., Jacques P.F., Bostom A.G., Wilson P.W., Rosenberg I.H. Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification. Public Health Rev. 28:2000;117-145.